BridgeBio Oncology Therapeutics Inc.

BBOT

BBOTBridgeBio Oncology Therapeutics Inc. US flag

NASDAQ Global Market

8.72

USD

+0.30

- -

698.53MMarket Cap

Income Statement (USD)

API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -
- Cost of Revenue	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -
Gross Profit	- -	- -	- -
+ Other Operating Income	- -	- -	- -
- Operating Expenses	65	81	146
+ Selling, General & Admin	8	8	25
+ Research & Development	56	73	121
+ Other Operating Expense	- -	- -	- -
Operating Income (Loss)	-65	-81	-146
- Non-Operating (Income) Loss	- -	-7	-12
+ Interest Expense, Net	- -	-6	-11
+ Interest Expense	- -	- -	- -
- Interest Income	- -	6	11
+ Other Non-Op (Income) Loss	- -	- -	- -
Pretax Income	-65	-74	-134
- Income Tax Expense (Benefit)	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -
Income (Loss) from Cont Ops	-65	-74	-134
- Net Extraordinary Losses (Gains)	- -	- -	- -
+ Discontinued Operations	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -
Income (Loss) Incl. MI	-65	-74	-134
- Minority Interest	- -	- -	- -
Net Income, GAAP	-65	-74	-134
- Preferred Dividends	- -	- -	- -
- Other Adjustments	- -	- -	- -
Net Income Avail to Common, GAAP	-65	-74	-134
EBIT	-65	-81	-146
EBITDA	-65	-81	-145
EBITDA Margin (%)	- -	- -	- -
EBITA	-65	-81	-146
Gross Margin (%)	- -	- -	- -
Operating Margin (%)	- -	- -	- -
Profit Margin (%)	- -	- -	- -
Sales per Employee	- -	- -	- -
Dividend per Share	- -	- -	- -
Depreciation Expense	- -	- -	1
Basic Weighted Avg Shares	79	79	31
Basic EPS, GAAP	-0.82	-0.94	-4.3
Basic EPS from Cont Ops	-0.82	-0.94	-4.3
Diluted Weighted Avg Shares	79	79	31
Diluted EPS, GAAP	-0.82	-0.94	-4.3
Diluted EPS from Cont Ops	-0.82	-0.94	-4.3

Balance Sheet (USD)

API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	4	159	432
+ Cash, Cash Equivalents & STI	- -	156	425
+ Cash & Cash Equivalents	- -	31	374
+ ST Investments	- -	125	52
+ Accounts & Notes Receiv	2	- -	- -
+ Accounts Receivable, Net	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -
+ Other Receivable, Net	2	- -	- -
+ Inventories	- -	- -	- -
+ Raw Materials	- -	- -	- -
+ Work In Process	- -	- -	- -
+ Finished Goods	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -
+ Other Inventory	- -	- -	- -
+ Other ST Assets	2	3	7
+ Misc ST Assets	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -
Total Noncurrent Assets	2	6	16
+ Property, Plant & Equip, Net	- -	- -	3
+ Property, Plant & Equip	- -	- -	3
- Accumulated Depreciation	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -
+ LT Investments	- -	- -	- -
+ LT Receivables	- -	- -	- -
+ Other LT Assets	2	5	13
+ Total Intangible Assets	- -	- -	- -
+ Goodwill	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -
+ Misc LT Assets	2	5	13
Total Assets	6	164	448
+ Payables & Accruals	17	13	29
+ Accounts Payable	1	3	1
+ Accrued Taxes	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -
+ Other Payables & Accruals	16	10	27
+ ST Debt	- -	- -	1
+ ST Borrowings	- -	- -	- -
+ ST Finance Leases	- -	- -	1
+ Other ST Liabilities	- -	7	6
+ Deferred Revenue	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Misc ST Liabilities	- -	7	6
Total Current Liabilities	17	20	35
+ LT Debt	- -	- -	2
+ LT Borrowings	- -	- -	- -
+ LT Finance Leases	- -	- -	2
+ Other LT Liabilities	105	323	- -
+ Accrued Liabilities	- -	- -	- -
+ Pension Liabilities	- -	- -	- -
+ Deferred Revenue	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Misc LT Liabilities	105	323	- -
Total Noncurrent Liabilities	105	323	2
Total Liabilities	122	343	37
+ Preferred Equity and Hybrid Capital	- -	- -	- -
+ Share Capital & APIC	33	44	768
+ Common Stock	- -	- -	- -
+ Additional Paid in Capital	33	44	768
- Treasury Stock	- -	- -	- -
+ Retained Earnings	-148	-223	-357
+ Other Equity	- -	- -	- -
Equity Before Minority Interest	-116	-179	411
+ Minority/Non Controlling Interest	- -	- -	- -
Total Equity	-116	-179	411
Total Liabilities & Equity	6	164	448
Shares Outstanding	79	79	80
Number of Employees	- -	- -	- -
Capital Leases - Total	- -	- -	3
Net Debt	- -	-31	-374
Net Debt to Equity	0.22	17.27	-90.9
Tangible Common Equity Ratio	-1,946.16	-108.73	91.68
Current Ratio	0.23	8.1	12.34
Cash Conversion Cycle	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-65	-74	-134
+ Depreciation & Amortization	- -	- -	1
+ Non-Cash Items	16	3	13
+ Stock-Based Compensation	16	4	6
+ Deferred Income Taxes	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -
+ Other Non-Cash Adj	- -	-1	7
+ Chg in Non-Cash Work Cap	-4	16	6
+ (Inc) Dec in Accts Receiv	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-1	-3
+ Inc (Dec) in Accts Payable	- -	11	18
+ Inc (Dec) in Other	-4	6	-8
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Operating Activities	-52	-55	-114
+ Change in Fixed & Intang	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	-1
+ Acq of Fixed Prod Assets	- -	- -	-1
+ Acq of Intangible Assets	- -	- -	- -
+ Cash (Repurchase) of Equity	4	1	- -
+ Increase in Capital Stock	4	1	- -
+ Decrease in Capital Stock	- -	- -	- -
+ Net Change in LT Investment	- -	-123	74
+ Dec in LT Investment	- -	32	158
+ Inc in LT Investment	- -	-154	-84
+ Net Cash From Acq & Div	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -
+ Cash for JVs	- -	- -	- -
+ Other Investing Activities	-2	2	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Investing Activities	-3	-121	73
+ Dividends Paid	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -
+ Cash From Debt	- -	- -	- -
+ Repayments of Debt	- -	- -	- -
+ Other Financing Activities	52	205	383
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Financing Activities	55	206	383
Effect of Foreign Exchange Rates	- -	- -	- -
Net Changes in Cash	- -	31	343
EBITDA	-65	-81	-145
EBITDA Margin (%)	- -	- -	- -
Free Cash Flow	-52	-55	-114
Net Cash Paid for Acquisitions	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -
Free Cash Flow to Equity	- -	-55	-114
Free Cash Flow per Basic Share	-0.66	-0.7	-3.68
Price/Free Cash Flow	- -	-15.13	-3.44
Cash Flow to Net Income	0.8	0.74	0.85
Capital Expenditures	- -	- -	-1